<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04808180</url>
  </required_header>
  <id_info>
    <org_study_id>2021-MIH</org_study_id>
    <nct_id>NCT04808180</nct_id>
  </id_info>
  <brief_title>Clinical Efficacy of Biomimetic Hydroxyapatite in the Treatment of Molar Incisor Hypomineralization.</brief_title>
  <official_title>Effects of Biomimetic Hydroxyapatite in the Treatment of Molar Incisor Hypomineralization: a Randomized Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pavia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pavia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the following study is to evaluate che clinical efficacy of a toothpaste with&#xD;
      biomimetic hydroxyapatite for the management of Molar-Incisor Hypomineralization. Patients&#xD;
      who agree to participate to the study will use Biorepair toothpaste for the first 7 days of&#xD;
      the month for 3, 6 and 9 months depending on the degree of demineralizations. Intact Toot®&#xD;
      Application will be used for the evaluation of the demineralizations during the study and the&#xD;
      following indices will be measured: BEWE, Bleeding Index, Gingival index, Plaque index and&#xD;
      the dental sensitivity test. Contralateral teeth will be used as control if not affected by&#xD;
      MIH; otherwise, adjacent teeth will be considered.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Informed consent will be signed by the parents of the patients underage; patients will be&#xD;
      asked the approval for the attendance of the study.&#xD;
&#xD;
      Adult patients will sign the informed consent for the treatment and for processing personal&#xD;
      data for research purpose, with their approval for the attendance of the study.&#xD;
&#xD;
      Patients will be given for free a toothpaste with biomimetic hydroxyapatite and the&#xD;
      Investigator will explain the correct procedures for home oral care. The toothpaste will be&#xD;
      applied the first 7 days of the month for 3 months (mild demineralizations), for 6 months&#xD;
      (moderate demineralizations) and for 9 months (severe demineralizations).&#xD;
&#xD;
      Demineralizations will be photographed and their size will be measured with Intact Tooth® app&#xD;
      (Addware Europe ltd, Dublin, Eire) at the beginning of the study and after 1, 2, 3, 6 and 9&#xD;
      months.&#xD;
&#xD;
      For each visit, BEWE index, Bleeding Index, Gingival index, Plaque index and Dental&#xD;
      sensitivity test. Teeth with MIH will be assessed, together with their contralaterals as&#xD;
      control. If the contralateral teeth should suffer from MIH too, measurements will be carried&#xD;
      out on the adjacent teeth.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 25, 2021</start_date>
  <completion_date type="Anticipated">February 3, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of BI - Bleeding Index</measure>
    <time_frame>Study begin, 1,2,3, 6 and 9 months</time_frame>
    <description>Scoring criteria:&#xD;
0: absence of bleeding after 30 seconds&#xD;
1: bleeding observed after 30 seconds&#xD;
2: immediate bleeding</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of GI - Gingival Index (Loe and Silness, 1963)</measure>
    <time_frame>Study begin, 1,2,3, 6 and 9 months</time_frame>
    <description>Scoring criteria:&#xD;
0 = normal gingiva.&#xD;
= mild inflammation, edema and swelling; no bleeding.&#xD;
= moderate inflammation with edema, swelling and bleeding on probing.&#xD;
= severe inflammation with marked edema, redness tissues, ulceration and spontaneous bleeding.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of PCR - Plaque Control Record (O'Leary, 1972)</measure>
    <time_frame>Study begin, 1,2,3, 6 and 9 months</time_frame>
    <description>4 surfaces scored (mesial, distal, vestibular, labial/palatal) per tooth by means of plaque relevator.&#xD;
The Index is calculated multiplying the total number of surfaces with plaque per 100.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of dental sensitivity - Dental sensitivity test</measure>
    <time_frame>Study begin, 1,2,3, 6 and 9 months</time_frame>
    <description>A compressed air flow and then a cold stimulus with water at 0°C. The intensity of discomfort is assessed thanks to a VAS scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of BEWE Index - Basic Erosive Wear Examination (Barlet et al., 2008)</measure>
    <time_frame>Study begin, 1,2,3, 6 and 9 months</time_frame>
    <description>Scoring criteria:&#xD;
0: no erosive tooth wear;&#xD;
1: initial loss of surface texture;&#xD;
2: distinct defect, hard tissue loss &lt; 50% of the surface area;&#xD;
3: hard tissue loss ≥ 50% of the surface area.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Molar Incisor Hypomineralization</condition>
  <arm_group>
    <arm_group_label>Trial Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Teeth from this group suffer from MIH. They will be evaluated after home oral care with BioRepair toothpaste containing microRepair®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Teeth from this group do not show demineralizations. They are the contralateral ones of the teeth of Trial group, or the adjacent ones in case they are affected from MIH. They will be evaluated after home oral care with toothpaste containing microRepair®.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biorepair Shock Treatment</intervention_name>
    <description>Patients from this group will use Biorepair Toothpaste for the first 7 days of the month for 3 months (mild demineralizations) and for 6 months (moderate demineralizations).</description>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_label>Trial Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  presence of at least 2 enamel demineralizations of permanent molars and incisors&#xD;
             (Molar-Incisor Hypomineralization - MIH) in two different quadrants&#xD;
&#xD;
          -  good general health (absence of systemic diseases)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients undergoing orthodontic therapy&#xD;
&#xD;
          -  patients taking drugs&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Scribante, DDS, PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pavia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Unit of Dental Hygiene - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Paediatrics - University of Pavia</name>
      <address>
        <city>Pavia</city>
        <state>Lombardy</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>March 16, 2021</study_first_submitted>
  <study_first_submitted_qc>March 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2021</study_first_posted>
  <last_update_submitted>November 6, 2021</last_update_submitted>
  <last_update_submitted_qc>November 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pavia</investigator_affiliation>
    <investigator_full_name>Andrea Scribante</investigator_full_name>
    <investigator_title>Research Resident, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>biomimetic hydroxyapatite</keyword>
  <keyword>enamel remineralization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dental Enamel Hypoplasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will be available upon motivated request to Principal Investigator</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

